Dimethyl Sulfoxide (DMSO)

Dimethyl Sulfoxide (DMSO)

Global Dimethyl Sulfoxide (DMSO) Market to Reach US$403.5 Million by 2030

The global market for Dimethyl Sulfoxide (DMSO) estimated at US$265.9 Million in the year 2023, is expected to reach US$403.5 Million by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Pharmaceuticals Application, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$217.7 Million by the end of the analysis period. Growth in the Electronics Application segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$49.5 Million While China is Forecast to Grow at 7.3% CAGR

The Dimethyl Sulfoxide (DMSO) market in the U.S. is estimated at US$49.5 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$186.2 Million by the year 2030 trailing a CAGR of 7.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Dimethyl Sulfoxide (DMSO) Market - Key Trends & Drivers Summarized

Dimethyl sulfoxide (DMSO) is a highly versatile organic solvent known for its exceptional ability to penetrate biological membranes and its diverse applications across various industries. DMSO is widely used as a solvent in chemical reactions due to its ability to dissolve both polar and non-polar compounds. DMSO is an important constituent of diverse array of applications across domains like chemicals, medicine, drug development, biology and medicine. In pharmaceuticals, DMSO is employed as a carrier for topical drugs, enhancing the absorption of active ingredients through the skin. It also serves as a cryoprotectant, protecting cells and tissues during the freezing process by preventing ice crystal formation, which is particularly valuable in medical and biological research for the preservation of stem cells, embryos, and other biological specimens.

Technological advancements have broadened the applications and improved the efficacy of DMSO in various fields. In the pharmaceutical industry, ongoing research has expanded its use in drug delivery systems and in formulations for treating conditions such as arthritis and bladder inflammation, leveraging its anti-inflammatory and analgesic properties. In agriculture, DMSO is used to enhance the effectiveness of pesticides and herbicides by improving their penetration into plant tissues. Additionally, DMSO`s role in biotechnology has grown, especially in the cryopreservation of cells and tissues, where its cryoprotective properties are critical for maintaining cell viability during storage and transport. The solvent`s ability to stabilize and preserve biomolecules has also made it invaluable in genetic and molecular biology research.

The growth in the Dimethyl Sulfoxide (DMSO) market is driven by several factors. The increasing demand for advanced pharmaceutical formulations and efficient drug delivery systems has significantly boosted the use of DMSO in the pharmaceutical industry. The rising focus on biotechnology and life sciences research, particularly in areas such as cryopreservation and molecular biology, is propelling market growth as well. Additionally, the agricultural sector`s need for more effective pest control solutions is contributing to the increased utilization of DMSO. Furthermore, regulatory approvals and positive endorsements from health authorities for specific medical and veterinary applications are facilitating market expansion. These factors, combined with continuous innovation and the broadening scope of DMSO applications, are ensuring robust growth in the DMSO market, reinforcing its importance across multiple scientific and industrial domains.

Select Competitors (Total 60 Featured) -

• Arkema Group
• FENGCHEN GROUP CO., LTD.
• Gaylord Chemical Company, LLC
• Glentham Life Sciences Ltd.
• Henan GP Chemicals Co., Ltd
• Honeywell International, Inc.
• Hubei Xingfa Chemicals Group Co. Ltd.
• Merck KGaA
• Otto Chemie Pvt. Ltd.
• Parchem Fine & Specialty Chemicals, Inc.
• Toray Fine Chemicals Co. Ltd.
• Zhuzhou Hansen Chemicals Co. Ltd.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.